A. Young

P.0829 Aripiprazole – relationship of serum concentrations to clinical effects and implications for oral delivery

D. Taylor, R. Pendleton, Suleyman Noordeen, 2021, European Neuropsychopharmacology.

Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A

Wei-sheng Chen, A. Young, De‐Feng Huang, 2009, Rheumatology International.

Antiglucocorticoid treatments for mood disorders.

A. Young, I. Ferrier, P. Gallagher, 2015, The Cochrane database of systematic reviews.

Aripiprazole in schizophrenia: consensus guidelines

S. Dursun, T. Burns, T. Fahy, 2005, International journal of clinical practice.

In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005

A. Young, M. Tohen, T. Ketter, 2010, European Psychiatry.

P0160 - A double-blind, placebo-controlled study with acute and continuation phase of Quetiapine and Lithium in adults with bipolar depression (Embolden I)

M. Brecher, A. Carlsson, A. Young, 2008, European Psychiatry.

Ketamine's pharmacokinetic and pharmacodynamic interactions with anticonvulsants, and their implications for psychiatry: A scoping review protocol

R. Strawbridge, M. Juruena, A. Young, 2023, medRxiv.